144 related articles for article (PubMed ID: 10893449)
1. Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene.
Inoue A; Narumi K; Matsubara N; Sugawara S; Saijo Y; Satoh K; Nukiwa T
Cancer Lett; 2000 Aug; 157(1):105-12. PubMed ID: 10893449
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer.
Schuler M; Rochlitz C; Horowitz JA; Schlegel J; Perruchoud AP; Kommoss F; Bolliger CT; Kauczor HU; Dalquen P; Fritz MA; Swanson S; Herrmann R; Huber C
Hum Gene Ther; 1998 Sep; 9(14):2075-82. PubMed ID: 9759934
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection.
Weill D; Mack M; Roth J; Swisher S; Proksch S; Merritt J; Nemunaitis J
Chest; 2000 Oct; 118(4):966-70. PubMed ID: 11035664
[TBL] [Abstract][Full Text] [Related]
4. Enhanced induction of Bax gene expression in H460 and H1299 cells with the combined treatment of cisplatin and adenovirus mediated wt-p53 gene transfer.
Choi JH; Ahn KS; Kim J; Hong YS
Exp Mol Med; 2000 Mar; 32(1):23-8. PubMed ID: 10762058
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.
Nemunaitis J; Swisher SG; Timmons T; Connors D; Mack M; Doerksen L; Weill D; Wait J; Lawrence DD; Kemp BL; Fossella F; Glisson BS; Hong WK; Khuri FR; Kurie JM; Lee JJ; Lee JS; Nguyen DM; Nesbitt JC; Perez-Soler R; Pisters KM; Putnam JB; Richli WR; Shin DM; Walsh GL; Merritt J; Roth J
J Clin Oncol; 2000 Feb; 18(3):609-22. PubMed ID: 10653876
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo.
Nishizaki M; Meyn RE; Levy LB; Atkinson EN; White RA; Roth JA; Ji L
Clin Cancer Res; 2001 Sep; 7(9):2887-97. PubMed ID: 11555607
[TBL] [Abstract][Full Text] [Related]
7. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
Mack PC; Gandara DR; Bowen C; Edelman MJ; Paglieroni T; Schnier JB; Gelmann EP; Gumerlock PH
Clin Cancer Res; 1999 Sep; 5(9):2596-604. PubMed ID: 10499638
[TBL] [Abstract][Full Text] [Related]
8. p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells.
Lai SL; Perng RP; Hwang J
J Biomed Sci; 2000; 7(1):64-70. PubMed ID: 10644891
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study.
Schuler M; Herrmann R; De Greve JL; Stewart AK; Gatzemeier U; Stewart DJ; Laufman L; Gralla R; Kuball J; Buhl R; Heussel CP; Kommoss F; Perruchoud AP; Shepherd FA; Fritz MA; Horowitz JA; Huber C; Rochlitz C
J Clin Oncol; 2001 Mar; 19(6):1750-8. PubMed ID: 11251006
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells.
Tango Y; Fujiwara T; Itoshima T; Takata Y; Katsuda K; Uno F; Ohtani S; Tani T; Roth JA; Tanaka N
Hum Gene Ther; 2002 Jul; 13(11):1373-82. PubMed ID: 12162819
[TBL] [Abstract][Full Text] [Related]
12. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.
Rohr UP; Wulf MA; Stahn S; Heyd F; Steidl U; Fenk R; Opalka B; Pitschke G; Prisack HB; Bojar H; Haas R; Kronenwett R
Cancer Gene Ther; 2003 Dec; 10(12):898-906. PubMed ID: 14712316
[TBL] [Abstract][Full Text] [Related]
13. Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cells.
Osaki S; Nakanishi Y; Takayama K; Pei XH; Ueno H; Hara N
Cancer Gene Ther; 2000 Feb; 7(2):300-7. PubMed ID: 10770640
[TBL] [Abstract][Full Text] [Related]
14. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent.
Ogawa N; Fujiwara T; Kagawa S; Nishizaki M; Morimoto Y; Tanida T; Hizuta A; Yasuda T; Roth JA; Tanaka N
Int J Cancer; 1997 Nov; 73(3):367-70. PubMed ID: 9359484
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-controlled p53 gene therapy for human non-small cell lung cancer xenografts in athymic nude mice via the CArG elements.
Wang WD; Li R; Chen ZT; Li DZ; Duan YZ; Cao ZH
Cancer Sci; 2005 Oct; 96(10):706-12. PubMed ID: 16232203
[TBL] [Abstract][Full Text] [Related]
16. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
18. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
19. Late resistance to adenoviral p53-mediated apoptosis caused by decreased expression of Coxsackie-adenovirus receptors in human lung cancer cells.
Tango Y; Taki M; Shirakiya Y; Ohtani S; Tokunaga N; Tsunemitsu Y; Kagawa S; Tani T; Tanaka N; Fujiwara T
Cancer Sci; 2004 May; 95(5):459-63. PubMed ID: 15132776
[TBL] [Abstract][Full Text] [Related]
20. Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer.
Kocdor H; Ates H; Aydin S; Cehreli R; Soyarat F; Kemanli P; Harmanci D; Cengiz H; Kocdor MA
Drug Des Devel Ther; 2015; 9():3899-909. PubMed ID: 26251569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
